Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04021693 · ClinicalTrials.gov registry record · NA

Learning Outcomes With Point-of-Care Ultrasound

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
47
Enrollment target

NCT04021693: Completed NA study, sponsored by Stanford University.

NCT04021693 is a NA study that has completed, run by Stanford University. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04021693, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target

Study Summary

Point-of care-ultrasonography has the potential to transform healthcare delivery through its diagnostic and therapeutic utility. Its use has become more widespread across a variety of clinical settings as more investigations have demonstrated its impact on patient care. This includes the use of point-of-care ultrasound by trainees, who are now utilizing this technology as part of their diagnostic assessments of patients. However, there are few studies that examine how efficiently trainees can learn point-of-care ultrasound and which training methods are more effective. The primary objective of this study is to assess whether handheld ultrasound devices, along with a year-long lecture series, improve internal medicine interns' knowledge and image interpretation skills with point-of-care ultrasound. Participants shall be randomized to receive personal access to handheld ultrasound devices to be used for learning vs. no personal access. The primary outcome will assess their interpretive ability with ultrasound images/videos. Secondary outcomes will include rates of device usage and lecture attendance.

Primary Outcome

Image assessments will include videos and photographs of ultrasound images that will require the intern to interpret the image.

Interventions

  • OTHER Handheld Ultrasound Devices

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2017-08-16
Est. Completion 2018-06-30
Phase NA
Stanford University

1,744 total trials

What the finished NCT04021693 record still lists

NCT04021693 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Handheld Ultrasound Devices is the first listed.

NCT04021693 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04021693 about?

NCT04021693 is a clinical study titled "Learning Outcomes With Point-of-Care Ultrasound". Point-of care-ultrasonography has the potential to transform healthcare delivery through its diagnostic and therapeutic utility. Its use has become more widespread across a variety of clinical settings as more investigations have demonstrated its impact on patient care. This includes the use of poin...

What is the current status of trial NCT04021693?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2017-08-16. Estimated completion is 2018-06-30.

What interventions are being tested in trial NCT04021693?

The interventions under investigation include: Handheld Ultrasound Devices (OTHER).

Who is sponsoring clinical trial NCT04021693?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04021693's enrollment target sits among peer trials

47 1400th of 2000 higher than 599 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04021693, the US trial registry maintained by the National Library of Medicine. NCT04021693 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.